Autopsy report · NCT01198873
Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 4 months before it stopped.
- 76 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Atrial Fibrillation
- Interventions
- Dronedarone; Placebo (for Dronedarone)
- Participants
- 76
- Sites
- 57
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.